As of December 2024 Glenmark Pharmaceuticals has a market cap of โฌ4.88 Billion. This makes Glenmark Pharmaceuticals the world's 2658th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2024 | โฌ4.88 B | 86.35% |
2023 | โฌ2.62 B | 94.54% |
2022 | โฌ1.34 B | -23.75% |
2021 | โฌ1.76 B | 14.31% |
2020 | โฌ1.54 B | 26.04% |
2019 | โฌ1.22 B | -49.73% |
2018 | โฌ2.44 B | 11.79% |
2017 | โฌ2.18 B | -37.74% |
2016 | โฌ3.50 B | -2.02% |
2015 | โฌ3.58 B | 32.07% |
2014 | โฌ2.71 B | 59.97% |
2013 | โฌ1.69 B | -14.1% |
2012 | โฌ1.97 B | 72.85% |
2011 | โฌ1.14 B | -30.57% |
2010 | โฌ1.64 B | 58.15% |
2009 | โฌ1.03 B | -5.15% |
2008 | โฌ1.09 B | -56.11% |
2007 | โฌ2.49 B | 305.65% |
2006 | โฌ0.61 B | 76.36% |
2005 | โฌ0.34 B |